Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

COVID-19 Impact on Lymphoma Patients' Clinical Outcomes - an Observational Cohort Study

Andrew Ip, MDMSc, Anthony Mato, MD, Jordan Intrator, Nicholas P Howard, Alessandra Petrillo, MD, Rosalba Vicioso, BA, Rani Sebti, MD, Cristina Cicogna, MD, Gabriella Magarelli, ACNP-BC, Lori A. Leslie, MD, Andre H. Goy, MD, Tatyana A. Feldman, MD

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-141871

Published: 2020

Journal Articles

Outcomes of Follicular Lymphoma Patients Treated with Frontline Bendamustine and Rituximab: Impact of Histologic Grade and Early Progression on Overall Survival

Allison M. Winter, MD, Loretta J. Nastoupil, MD, Melody R. Becnel, MD, James R. Cerhan, MD PhD, Thomas M. Habermann, MD, Brian K. Link, MD, Matthew J. Maurer, MS, Bita Fakhri, MD MPH, Prathima Reddy, MD, Stephen D. Smith, MD, Dhruvika Mukhija, MD, Deepa Jagadeesh, MD MPH, Amrita Desai, MD, Juan Pablo Alderuccio, MD, Izidore S. Lossos, MD, Pooja Mehra, MD, Craig A. Portell, MD, Christopher R. D'Angelo, MD, Vaishalee P. Kenkre, MD, Max L. Goldman, MD, Oscar Calzada, BS, Jonathon B. Cohen, MD MS, Mohammad Junaid Hussain, MD, Nilanjan Ghosh, MD PhD, Yang Liu, MD, Stefan Klaus Barta, MD MRCP, MS, Paolo F Caimi, MD, Adam Kittai, MD, Alexey V Danilov, MD PhD, Timothy Tiutan, MD, Peter Martin, FRCPC, MD MS, Nathalie Danielson, MSN, RN, ACNP-BC, Manali Kamdar, MD, Abhigna Kodali, MD, Andrew M. Evens, DO, MSc, Brad S Kahl, MD, Brian T. Hill, MD PhD

Blood (2018) 132 (Supplement 1): 4146.

https://doi.org/10.1182/blood-2018-99-118530

Published: 2018

Journal Articles

A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Ajai Chari, MD, Hearn Jay Cho, MD PhD, Samir Parekh, MD, Kenneth Lau, Gillian Morgan, RN, Donna Catamero, ANP-BC, Melissa Cortes, AGPCNP-BC, Meredith Curtis, AGPCNP-BC, Juliet Escalon, NP, Erika Florendo, ANP-BC, Daniel Verina, ACNP-BC, Nadege Stevens, RN, Elaine Chan, BS, Katarzyna Garcia, MS / CCRP, Lisa La, MS/CCRP, Marisa Shields, Gina Strumolo, MA, Sundar Jagannath, MD

Blood (2016) 128 (22): 4520.

https://doi.org/10.1182/blood.V128.22.4520.4520

Published: 2016

Journal Articles

Yearly Long-Acting Zoledronic Acid (Reclast) Is Safe and Effective for Treatment of Bone Loss after Hematopoietic Stem Cell Transplantation

Zhuoyan Li, MD, Samuel M Rubinstein, MD, Carey Clifton, ACNP, Leigh Ann Vaughan, ACNP, Melissa Logue, ACNP, Michael T. Byrne, DO, Adetola A. Kassim, MD MS, Brian G Engelhardt, MD, Wichai Chinratanalab, MD, Salyka Sengsayadeth, MD, Stephen J. Brandt, MD, Stacey A. Goodman, MD MS, John P. Greer, MD, Madan Jagasia, MD, Bipin N. Savani, MD

Blood (2016) 128 (22): 3438.

https://doi.org/10.1182/blood.V128.22.3438.3438

Published: 2016

Journal Articles

Extended Duration of Anti-Thymocyte Globulin (ATG) Administration May Reduce the Risk of Graft-Versus-Host Disease in Patients with Aplastic Anemia Undergoing Matched-Related Allogeneic Peripheral Blood Stem Cell Transplantation

Laura A. Zider, MSN, ACNP-BC, RN, Amanda N. Seddon, PharmD, Sunita Nathan, MD, John J. Maciejewski, MD PhD, Jamile M. Shammo, MD, Gorgun Akpek, MD MHS

Blood (2016) 128 (22): 5876.

https://doi.org/10.1182/blood.V128.22.5876.5876

Published: 2016

Journal Articles

Six-Minute Walk Test As a Measure of Functional Change after Chemotherapy in Cardiac AL Amyloidosis

Ilka Decker, MD MS, Oluchi C. Ukaegbu, MD, Stacey A. Goodman, MD MS, Daniel J. Lenihan, MD, Rebecca R Hung, MD, Adetola A. Kassim, MD MS, Shelton L. Harrell, MSN, ACNP-BC, Kevin McDonagh, MD, Sharon E. Phillips, MSPH, Kyle T Rawling, Samuel M Rubinstein, MD, Tarsheen K. Sethi, MD MS, Robert F Cornell, MD MS

Blood (2015) 126 (23): 1841.

https://doi.org/10.1182/blood.V126.23.1841.1841

Published: 2015

Journal Articles

Comparison of Safety Reports to the FDA from a Pilot Introduction of Peginesatide, a Third Generation Erythropoiesis Stimulating Agent Versus Those from the Usual Care Setting: Manufacturers of Biosimilars and the FDA Should Consider Pilot Introductions of These Agents

Charles L. Bennett, MD PhD, Sony Jacob, MD, Peter Georgantopoulos, MPH, MA, Judy Nichols, MSN, ACNP, Iain C Macdougall, MD

Blood (2014) 124 (21): 3516.

https://doi.org/10.1182/blood.V124.21.3516.3516

Published: 2014

Journal Articles

Symptom Burden In Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Loretta A. Williams, PhD, RN, Patricia S. Ault, MS, ACNP, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD, Alfonso Quintas-Cardama, MD, Gautam Borthakur, MD, Stefan H. Faderl, MD, Elias J. Jabbour, MD, Charles S. Cleeland, PhD, Jorge E. Cortes, MD

Blood (2013) 122 (21): 2988.

https://doi.org/10.1182/blood.V122.21.2988.2988

Published: 2013

Journal Articles

Immune Reconstitution and Quality of Life Analyses After Autologous Transplant for Multiple Myeloma

Craig C. Hofmeister, MD, Mindy A Bowers, BS, Anissa Bingman, M.S., Gerard Lozanski, M.D., Robert A. Baiocchi, M.D., Ph.D., William Falk, B.S., Don M. Benson, Jr., MD, PhD, Yvonne A Efebera, M.D., Kristina Humphries, M.S., Megan Sell, RN, MS, Carli N Greenfield, RN, MSN, ACNP, Mark E Lustberg, MD, PhD, John L. Vaughn, BS, Christian Tyler Earl, Susan Geyer, PhD, Steven M. Devine, MD

Blood (2012) 120 (21): 4460.

https://doi.org/10.1182/blood.V120.21.4460.4460

Published: 2012

Journal Articles

Follow-up in Long Term Transplant Clinic Overcomes the Barrier of Geographic Distance From Transplant Center

Brittany Knick Ragon, MD, Carey Clifton, ACNP, Bipin N. Savani, MD, Brian Engelhardt, MD, Adetola A Kassim, MD, Leigh Ann Vaughan, ACNP, Catherine Lucid, ACNP, Madan Jagasia, MBBS, MS

Blood (2012) 120 (21): 2070.

https://doi.org/10.1182/blood.V120.21.2070.2070

Published: 2012

Journal Articles

Post Autologous Transplant Vorinostat (SAHA) in High Risk Lymphoma: Phase 1 Study of Vorinostat Maintenance

Craig C. Hofmeister, MD, Mindy A Bowers, BS, Robert A. Baiocchi, M.D., Ph.D., Gerard Lozanski, M.D., Kristina Humphries, M.S., Kristie A. Blum, MD, Pierluigi Porcu, MD, Sam Penza, MD, Carli N Greenfield, RN, MSN, ACNP, Megan Sell, RN, MS, Christian Tyler Earl, Joseph Zitesman, B.S., Carl Quinion, Mark E Lustberg, MD, PhD, Leslie A Andritsos, MD, Steven M. Devine, MD

Blood (2012) 120 (21): 2004.

https://doi.org/10.1182/blood.V120.21.2004.2004

Published: 2012

Journal Articles

Relationship of Patient-Reported Symptoms to Daily Functioning in Chronic Myeloid Leukemia

Loretta A Williams, PhD, RN, Patricia S Ault, MS, ACNP, Araceli Garcia-Gonzalez, MD, Furong Huang, MS, Mary L Sailors, PhD, Charles S Cleeland, PhD, Jorge E. Cortes, MD

Blood (2012) 120 (21): 4260.

https://doi.org/10.1182/blood.V120.21.4260.4260

Published: 2012

Journal Articles

Phase I Trial of Lenalidomide + Vorinostat After Autologous Transplant in Multiple Myeloma.

Craig C. Hofmeister, MD, Mindy A Bowers, BS, Yvonne A Efebera, M.D., Kristina Humphries, M.S., Don M. Benson, Jr., MD, PhD, Carli N Greenfield, RN, MSN, ACNP, Megan Sell, RN, MS, Steven M. Devine, MD

Blood (2012) 120 (21): 3114.

https://doi.org/10.1182/blood.V120.21.3114.3114

Published: 2012

Journal Articles

Phase I Study of AR-42 in Relapsed Multiple Myeloma and Lymphoma.

Craig C. Hofmeister, MD, Zhongfa Liu, Ph.D., Mindy A Bowers, BS, Pierluigi Porcu, MD, Joseph M. Flynn, DO, MPH, Beth Christian, MD, Robert A. Baiocchi, M.D., Ph.D., Don M. Benson, Jr., MD, PhD, Leslie A Andritsos, MD, Carli N Greenfield, RN, MSN, ACNP, Megan Sell, RN, MS, Susan Geyer, PhD, John C. Byrd, MD, Michael R. Grever, MD

Blood (2012) 120 (21): 2955.

https://doi.org/10.1182/blood.V120.21.2955.2955

Published: 2012

Journal Articles

Identifying High Symptom Burden in Patients with Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitor Therapy

Loretta A Williams, PhD, RN, Patricia S Ault, MS, ACNP, Araceli Garcia-Gonzalez, MD, PhD, Quiling Shi, MD, PhD, Janet L Williams, MPH, Charles S Cleeland, PhD, Jorge E. Cortes

Blood (2011) 118 (21): 3138.

https://doi.org/10.1182/blood.V118.21.3138.3138

Published: 2011

Journal Articles

Multicenter Analysis of Elderly Hodgkin Lymphoma (eHL): Outcomes and Prognostic Factors in the Modern Era

Andrew M. Evens, DO, MSc, Irene Helenowski, MS, Chadi Nabhan, MD, FACP, Erika Ramsdale, MD, June M McKoy, MD, JD, MPH, MBA, Annette Larsen, B.A., R.N., Sarah Miyata, RN, MSN, ACNP, Benjamin Parsons, DO, Reem Karmali, MD, Britt E. Hanson, DO, Leo I. Gordon, MD, FACP, Scott E. Smith, MD, PhD, FACP, Stephanie A. Gregory, MD, Sonali M. Smith, MD

Blood (2011) 118 (21): 2625.

https://doi.org/10.1182/blood.V118.21.2625.2625

Published: 2011

Journal Articles

Fatigue in Chronic Myelogenous Leukemia Patients (pts) Treated with Tyrosine Kinase Inhibitors (TKI),

Aziz Nazha, Loretta A Williams, PhD, RN, Hagop M. Kantarjian, Patricia S Ault, MS, ACNP, Araceli Garcia-Gonzalez, MD, PhD, Janet L Williams, MPH, Alexandra Probst, Susan O'Brien, Elias Jabbour, Alfonso Quintas-Cardama, MD, Quiling Shi, MD, PhD, Charles S Cleeland, PhD, Jorge E. Cortes

Blood (2011) 118 (21): 3785.

https://doi.org/10.1182/blood.V118.21.3785.3785

Published: 2011

Journal Articles

Symptom Burden In Patients with Chronic Myeloid Leukemia (CML) on Kinase Inhibitor (KI) Therapy.

Loretta A Williams, PhD, RN, Araceli Garcia-Gonzalez, MD, Patricia S Ault, MS, ACNP, Janet L Williams, MPH, Gary M Mobley, MA, Tito R Mendoza, PhD, Charles S Cleeland, PhD, Jorge E. Cortes

Blood (2010) 116 (21): 3838.

https://doi.org/10.1182/blood.V116.21.3838.3838

Published: 2010

Journal Articles

Tablet-Based Assessment of Fatigue, Depression, and Pain In Myeloma Patients: Cohort Study of Inflammatory Cytokines and QOL Measures In the Newly Diagnosed, Patients on Lenalidomide, and Survivors.

Craig C. Hofmeister, MD, Gisele Rieser, RN, Mindy A Bowers, BS, Lisa C Merritt, RN, BSN, Carli N Greenfield, RN, MSN, ACNP, Yvonne A Efebera, MD, Don M Benson, Jr., MD, Steven M Devine, MD, Janet S de Moor, MPH, PhD

Blood (2010) 116 (21): 3807.

https://doi.org/10.1182/blood.V116.21.3807.3807

Published: 2010

Journal Articles

Timed Sequential Induction Therapy with Cytarabine and Mitoxantrone In Acute Myeloid Leukemia (AML): A Well-Tolerated Regimen with High Response Rates In Older Patients and Transformed AML.

Sheena Sahota, M.D., Melissa L Larson, MD, Margaret C Keller, ACNP, Jamile M. Shammo, MD, Allison Zindell, Bharathi Muthusamy, Stephanie A. Gregory, MD, Parameswaran Venugopal, MD

Blood (2010) 116 (21): 1068.

https://doi.org/10.1182/blood.V116.21.1068.1068

Published: 2010

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

COVID-19 Impact on Lymphoma Patients' Clinical Outcomes - an Observational Cohort Study

Outcomes of Follicular Lymphoma Patients Treated with Frontline Bendamustine and Rituximab: Impact of Histologic Grade and Early Progression on Overall Survival

A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Yearly Long-Acting Zoledronic Acid (Reclast) Is Safe and Effective for Treatment of Bone Loss after Hematopoietic Stem Cell Transplantation

Extended Duration of Anti-Thymocyte Globulin (ATG) Administration May Reduce the Risk of Graft-Versus-Host Disease in Patients with Aplastic Anemia Undergoing Matched-Related Allogeneic Peripheral Blood Stem Cell Transplantation

Six-Minute Walk Test As a Measure of Functional Change after Chemotherapy in Cardiac AL Amyloidosis

Comparison of Safety Reports to the FDA from a Pilot Introduction of Peginesatide, a Third Generation Erythropoiesis Stimulating Agent Versus Those from the Usual Care Setting: Manufacturers of Biosimilars and the FDA Should Consider Pilot Introductions of These Agents

Symptom Burden In Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Immune Reconstitution and Quality of Life Analyses After Autologous Transplant for Multiple Myeloma

Follow-up in Long Term Transplant Clinic Overcomes the Barrier of Geographic Distance From Transplant Center

Post Autologous Transplant Vorinostat (SAHA) in High Risk Lymphoma: Phase 1 Study of Vorinostat Maintenance

Relationship of Patient-Reported Symptoms to Daily Functioning in Chronic Myeloid Leukemia

Phase I Trial of Lenalidomide + Vorinostat After Autologous Transplant in Multiple Myeloma.

Phase I Study of AR-42 in Relapsed Multiple Myeloma and Lymphoma.

Identifying High Symptom Burden in Patients with Chronic Myeloid Leukemia on Tyrosine Kinase Inhibitor Therapy

Multicenter Analysis of Elderly Hodgkin Lymphoma (eHL): Outcomes and Prognostic Factors in the Modern Era

Fatigue in Chronic Myelogenous Leukemia Patients (pts) Treated with Tyrosine Kinase Inhibitors (TKI),

Symptom Burden In Patients with Chronic Myeloid Leukemia (CML) on Kinase Inhibitor (KI) Therapy.

Tablet-Based Assessment of Fatigue, Depression, and Pain In Myeloma Patients: Cohort Study of Inflammatory Cytokines and QOL Measures In the Newly Diagnosed, Patients on Lenalidomide, and Survivors.

Timed Sequential Induction Therapy with Cytarabine and Mitoxantrone In Acute Myeloid Leukemia (AML): A Well-Tolerated Regimen with High Response Rates In Older Patients and Transformed AML.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only